Overview

Induction of Puberty With 17-beta Estradiol in Girls With Turner Syndrome

Status:
Completed
Trial end date:
2004-07-26
Target enrollment:
Participant gender:
Summary
This trial is conducted in Europe. The aim of the trial is to induce normal pubertal development in girls with Turner Syndrome in accordance with that of their peers and their individual state psychosocial maturation.
Phase:
Phase 3
Details
Lead Sponsor:
Novo Nordisk A/S
Treatments:
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Polyestradiol phosphate